Global Gastrointestinal Therapeutics Market Size Study & Forecast, by Drug Class, by Application, by Distribution Channel and Regional Analysis, 2023-2030

Description

List of Tables

Global Gastrointestinal Therapeutics Market is valued at approximately USD 39.5 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5% over the forecast period 2023-2030. Gastrointestinal therapeutics is a specific area of medicine that aims to identify and manage disorders that affect the gastrointestinal tract. It is primarily concerned with treating issues that affect the organs within the gastrointestinal system, such as the stomach, small intestine, large intestine, and rectum. It involves various interventions, including medications that aim to alleviate symptoms, improve the overall function of the gastrointestinal system, and enhance the quality of life for individuals affected by these conditions. The market for these treatments is driven by factors such as an increase in the incidence of gastrointestinal disorders, a growing geriatric population, and the launch of new products by key companies. However, the market growth is hindered by strict government regulations regarding the approval of biosimilars and the expiration of drug patents during the forecast period of 2023-2030.

The growth of the gastrointestinal therapeutics market is being fueled by a surge in the prevalence of gastrointestinal diseases such as Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS), and gastrointestinal cancers. According to an article published by the National Stem Cell Foundation, in 2023, over 80 different autoimmune diseases affect nearly 4% of the world population, with the most common being type 1 diabetes, rheumatoid arthritis, lupus, Crohn's disease, multiple sclerosis , scleroderma, and psoriasis. Additionally, the increase in elderly individuals who are more susceptible to gastrointestinal conditions has led to a rise in demand for gastrointestinal therapeutics. According to an article published by the National Center for Biotechnology and Information (NCBI) in 2023, which reported that the burden of inflammatory bowel disease (IBD) is increasing worldwide, with a particular increase in prevalence in the elderly population. Furthermore, patients increased awareness of gastrointestinal disorders and available treatments has led to higher diagnosis rates and increased demand for therapeutics, contributing to market growth. Advances in pharmaceutical research and development have also led to the discovery of new drugs, novel delivery systems, and targeted therapies, providing opportunities for the market. Precision medicine, biologics, and personalized treatment approaches are expanding the treatment options available for various gastrointestinal conditions. For example, in June 2023, AbbVie Inc. announced positive top-line results from its Phase 3 maintenance study, COMMAND, showing Risankizumab (SKYRIZI) achieved the primary endpoint of clinical remission at week 52, as well as key secondary endpoints in adult patients with moderately to severely active ulcerative colitis.

The key regions considered for the Global Gastrointestinal Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. In 2022, North America was the dominant market for gastrointestinal therapeutics due to the presence of several major players in the region. The well-established healthcare infrastructure, high purchasing power, and increased adoption of gastrointestinal therapeutics also contributed to the market's growth. Additionally, key players in the region launched new products and obtained product approvals, further boosting market growth. Asia Pacific is expected to experience significant growth over the forecast period due to factors such as changing dietary habits, urbanization, lifestyle shifts, and an aging population leading to a rise in the prevalence of gastrointestinal disorders.

Major market player included in this report are:

Bristol-Myers Squibb Company
AbbVie Inc.
Pfizer Inc.
AstraZeneca plc
Bayer AG
Takeda Pharmaceutical Company Limited
Organon Group of Companies
Bausch Health Companies Inc.
Cosmo Pharmaceuticals N.V.
Teva Pharmaceutical Industries Limited

Recent Developments in the Market:

In May 2023, AbbVie announced that RINVOQ has been approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderately to severely active Crohn's disease who have not responded well to one or more TNF blockers, or cannot tolerate them. Additionally, in April 2023, AbbVie reported that RINVOQ has also been approved by the European Commission (EC) as the first oral Janus Kinase (JAK) inhibitor to treat adult patients with moderately to severely active Crohn's disease.
In May 2021, Bristol Myers Squibb made an announcement that the U.S. Food and Drug Administration (FDA) approved Zeposia (ozanimod) 0.92 mg to treat adults with moderately to severely active ulcerative colitis (UC), which is a chronic Inflammatory Bowel Disease (IBD).
In January 2021, AstraZeneca, and Daiichi Sankyo Company, Limited announced the U.S. approval for Enhertu to treat HER2-positive Gastric or Gastroesophageal Junction (GEJ) adenocarcinoma in adults who have received a previous trastuzumab-based regimen.

Global Gastrointestinal Therapeutics Market Report Scope:

Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Drug Class, Application, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Biologics
Proton Pump Inhibitors
Aminosalicylates
Antacids
Laxatives
H2 Antagonists
Others

By Application:

Inflammatory Bowel Disease
Gastroesophageal Reflux Disease
Peptic Ulcer Disease
Irritable Bowel Syndrome
Others

By Distribution Channel:

Hospitals Pharmacies
Drug Stores
Retail Pharmacies
Online Providers

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Gastrointestinal Therapeutics Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Gastrointestinal Therapeutics Market, by Drug Class, 2020-2030 (USD Billion)
- 1.2.3. Gastrointestinal Therapeutics Market, by Application, 2020-2030 (USD Billion)
- 1.2.4. Gastrointestinal Therapeutics Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Gastrointestinal Therapeutics Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Gastrointestinal Therapeutics Market Dynamics

3.1. Gastrointestinal Therapeutics Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increase in prevalence of gastrointestinal diseases
  - 3.1.1.2. Rise in geriatric population
  - 3.1.1.3. Rise in the number of product launches
- 3.1.2. Market Challenges
  - 3.1.2.1. Stringent government regulations toward approval of biosimilars
  - 3.1.2.2. Expiration of the drugs patent
- 3.1.3. Market Opportunities
  - 3.1.3.1. Rise in Research & Development activities
  - 3.1.3.2. Growth opportunities in emerging markets

Chapter 4. Global Gastrointestinal Therapeutics Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Gastrointestinal Therapeutics Market, by Drug Class

5.1. Market Snapshot
5.2. Global Gastrointestinal Therapeutics Market by Drug Class, Performance - Potential Analysis
5.3. Global Gastrointestinal Therapeutics Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Gastrointestinal Therapeutics Market, Sub Segment Analysis
- 5.4.1. Biologics
- 5.4.2. Proton Pump Inhibitors
- 5.4.3. Aminosalicylates
- 5.4.4. Antacids
- 5.4.5. Laxatives
- 5.4.6. H2 Antagonists
- 5.4.7. Others

Chapter 6. Global Gastrointestinal Therapeutics Market, by Application

6.1. Market Snapshot
6.2. Global Gastrointestinal Therapeutics Market by Application, Performance - Potential Analysis
6.3. Global Gastrointestinal Therapeutics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Gastrointestinal Therapeutics Market, Sub Segment Analysis
- 6.4.1. Inflammatory Bowel Disease
- 6.4.2. Gastroesophageal Reflux Disease
- 6.4.3. Peptic Ulcer Disease
- 6.4.4. Irritable Bowel Syndrome
- 6.4.5. Others

Chapter 7. Global Gastrointestinal Therapeutics Market, by Distribution Channel

7.1. Market Snapshot
7.2. Global Gastrointestinal Therapeutics Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Gastrointestinal Therapeutics Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Gastrointestinal Therapeutics Market, Sub Segment Analysis
- 7.4.1. Hospitals Pharmacies
- 7.4.2. Drug Stores
- 7.4.3. Retail Pharmacies
- 7.4.4. Online Providers

Chapter 8. Global Gastrointestinal Therapeutics Market, Regional Analysis

8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Gastrointestinal Therapeutics Market, Regional Market Snapshot
8.4. North America Gastrointestinal Therapeutics Market
- 8.4.1. U.S. Gastrointestinal Therapeutics Market
  - 8.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Gastrointestinal Therapeutics Market
8.5. Europe Gastrointestinal Therapeutics Market Snapshot
- 8.5.1. U.K. Gastrointestinal Therapeutics Market
- 8.5.2. Germany Gastrointestinal Therapeutics Market
- 8.5.3. France Gastrointestinal Therapeutics Market
- 8.5.4. Spain Gastrointestinal Therapeutics Market
- 8.5.5. Italy Gastrointestinal Therapeutics Market
- 8.5.6. Rest of Europe Gastrointestinal Therapeutics Market
8.6. Asia-Pacific Gastrointestinal Therapeutics Market Snapshot
- 8.6.1. China Gastrointestinal Therapeutics Market
- 8.6.2. India Gastrointestinal Therapeutics Market
- 8.6.3. Japan Gastrointestinal Therapeutics Market
- 8.6.4. Australia Gastrointestinal Therapeutics Market
- 8.6.5. South Korea Gastrointestinal Therapeutics Market
- 8.6.6. Rest of Asia Pacific Gastrointestinal Therapeutics Market
8.7. Latin America Gastrointestinal Therapeutics Market Snapshot
- 8.7.1. Brazil Gastrointestinal Therapeutics Market
- 8.7.2. Mexico Gastrointestinal Therapeutics Market
8.8. Middle East & Africa Gastrointestinal Therapeutics Market
- 8.8.1. Saudi Arabia Gastrointestinal Therapeutics Market
- 8.8.2. South Africa Gastrointestinal Therapeutics Market
- 8.8.3. Rest of Middle East & Africa Gastrointestinal Therapeutics Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Bristol-Myers Squibb Company
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Recent Developments
- 9.3.2. AbbVie Inc.
- 9.3.3. Pfizer Inc.
- 9.3.4. AstraZeneca plc
- 9.3.5. Bayer AG
- 9.3.6. Takeda Pharmaceutical Company Limited
- 9.3.7. Organon Group of Companies
- 9.3.8. Bausch Health Companies Inc.
- 9.3.9. Cosmo Pharmaceuticals N.V.
- 9.3.10. Teva Pharmaceutical Industries Limited

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Gastrointestinal Therapeutics Market, report scope
TABLE 2. Global Gastrointestinal Therapeutics Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Gastrointestinal Therapeutics Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
TABLE 4. Global Gastrointestinal Therapeutics Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Gastrointestinal Therapeutics Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 6. Global Gastrointestinal Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Gastrointestinal Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Gastrointestinal Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Gastrointestinal Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Gastrointestinal Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Gastrointestinal Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Gastrointestinal Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Gastrointestinal Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Gastrointestinal Therapeutics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Gastrointestinal Therapeutics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Gastrointestinal Therapeutics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Gastrointestinal Therapeutics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Gastrointestinal Therapeutics Market
TABLE 71. List of primary sources, used in the study of global Gastrointestinal Therapeutics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Gastrointestinal Therapeutics Market, research methodology
FIG 2. Global Gastrointestinal Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Gastrointestinal Therapeutics Market, key trends 2022
FIG 5. Global Gastrointestinal Therapeutics Market, growth prospects 2023-2030
FIG 6. Global Gastrointestinal Therapeutics Market, porters 5 force model
FIG 7. Global Gastrointestinal Therapeutics Market, pest analysis
FIG 8. Global Gastrointestinal Therapeutics Market, value chain analysis
FIG 9. Global Gastrointestinal Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Gastrointestinal Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Gastrointestinal Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Gastrointestinal Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Gastrointestinal Therapeutics Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Gastrointestinal Therapeutics Market, regional snapshot 2020 & 2030
FIG 15. North America Gastrointestinal Therapeutics Market 2020 & 2030 (USD Billion)
FIG 16. Europe Gastrointestinal Therapeutics Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Gastrointestinal Therapeutics Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Gastrointestinal Therapeutics Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Gastrointestinal Therapeutics Market 2020 & 2030 (USD Billion)